Quadrant Capital Group’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-474
| Closed | -$14.8K | – | 2342 |
|
|
2025
Q1 | $14.8K | Buy |
474
+89
| +23% | +$2.77K | ﹤0.01% | 2128 |
|
|
2024
Q4 | $9.82K | Sell |
385
-775
| -67% | -$19.8K | ﹤0.01% | 2131 |
|
|
2024
Q3 | $32.8K | Sell |
1,160
-618
| -35% | -$17.5K | ﹤0.01% | 1677 |
|
|
2024
Q2 | $46.9K | Sell |
1,778
-2,210
| -55% | -$58.3K | ﹤0.01% | 1438 |
|
|
2024
Q1 | $121K | Buy |
3,988
+501
| +14% | +$15.2K | 0.01% | 902 |
|
|
2023
Q4 | $98K | Buy |
3,487
+2,606
| +296% | +$73.2K | 0.01% | 1013 |
|
|
2023
Q3 | $23.9K | Buy |
881
+652
| +285% | +$17.7K | ﹤0.01% | 1630 |
|
|
2023
Q2 | $7.04K | Sell |
229
-290
| -56% | -$8.92K | ﹤0.01% | 2117 |
|
|
2023
Q1 | $18.7K | Buy |
519
+283
| +120% | +$10.2K | ﹤0.01% | 1735 |
|
|
2022
Q4 | $9.33K | Sell |
236
-13
| -5% | -$514 | ﹤0.01% | 1982 |
|
|
2022
Q3 | $10K | Sell |
249
-118
| -32% | -$4.74K | ﹤0.01% | 1898 |
|
|
2022
Q2 | $15K | Sell |
367
-7
| -2% | -$286 | ﹤0.01% | 1446 |
|
|
2022
Q1 | $14K | Buy |
374
+122
| +48% | +$4.57K | ﹤0.01% | 1507 |
|
|
2021
Q4 | $10K | Buy |
252
+202
| +404% | +$8.02K | ﹤0.01% | 1638 |
|
|
2021
Q3 | $2K | Sell |
50
-217
| -81% | -$8.68K | ﹤0.01% | 2187 |
|
|
2021
Q2 | $11K | Buy |
267
+264
| +8,800% | +$10.9K | ﹤0.01% | 1517 |
|
|
2021
Q1 | $0 | Hold |
3
| – | – | ﹤0.01% | 2447 |
|
|
2020
Q4 | $0 | Buy |
+3
| New | – | ﹤0.01% | 2365 |
|